Exploring Replacement of Best-Selling Drug and Future Growth Strategies

This chapter explores the pharmaceutical company's portfolio, including the replacement for their top-selling psoriasis drug, Stellara, new products like Darsalax, successful products Trampia and Lita, recent cardiology acquisition, and financing strategies for future growth.